Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Certified Medical …

Certified practices have more practice systems, modestly higher performance on measures of quality diabetes care

Normal-weight but metabolically unhealthy women have twofold greater incidence of diabetes

Guidelines relate to diagnosis of thyroid disease, indications for thyroidectomy, periop management

Favorable glucose metabolic biomarker profile seen among women with a history of gestational diabetes

Little evidence found of links with trajectories of blood pressure, lipids, hemoglobin A1c, anthropometry

Study suggests glucose tolerance improves with antidepressant discontinuation or dose reduction

Patients with higher comorbidity burden more likely to be treated with insulin for T2DM

Findings seen in trial of integration of intensive behavioral therapy into primary care practice

In retrospective study of adults with uncontrolled T2DM, 42.7 percent declined insulin therapy